Overview

When working with different CDMO’s and CRO’s, pharmaceutical companies face different challenges such as the lack of communication and alignment between all parties resulting in delays, errors and inconsistent feedback from clinic to formulation optimization. These are just a few of the challenges which the health science industry is facing and can be addressed with a seamless dedicated program management through one point of contact.

We invite you to our SGS LinkedIn Live: How to streamline the drug development pathway from preclinic to FIH/POC?, where Dr. Jelle Klein, Medical Director, SGS Clinical Research – CPU and Mike Frodsham, Chief Technical Officer CDMO, SGS Quay will explain the challenges the industry are facing, and how “SGS PACE” looks to support pharma and biopharma companies in their drug development journey, resulting in increased flexibility, efficiency and speed.

Objective

Our experts discuss how building a bespoke pathway from pre-clinical through to FIH / POC, with one provider, will overcome the current challenges of working with different CDMO’s and CRO’s. Discover how SGS PACE brings together bioanalysis, formulation and manufacturing and clinical research services through one partner and one dedicated point of contact.

Jelle Klein, Medical Director at SGS Clinical Research – CPU and Mike Frodsham, Chief Technical Officer, SGS Quay CDMO will highlight the flexible project delivery, providing you with the ultimate program to deliver clinical results effectively and efficiently.

Join the session, as they guide you through an expert-directed roadmap to clinic through one program manager - saving valuable time.

Agenda

  • Introduction
  • Discover how SGS PACE brings together bioanalysis, formulation and manufacturing and clinical research services through one partner and one dedicated point of contact
  • The challenges which the health science industry is facing and how they can be addressed with a seamless dedicated program management through one point of contact
  • In what ways does working with one organization help a customer and what kind of timelines can they expect
  • How SGS PACE brings together world-leading clinical drug development through one point of contact and organization
  • Conclusion
  • Q&A

Target Audience: The webinar is aimed at all Pharmaceutical and Biopharmaceutical companies.

Language: English

For further information, please contact: healthscience@sgs.com

_1743064951981